Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

RxSpan MD vs VivioMD

By GLP-1 ScorecardUpdated

RxSpan MD
Site position #4

Higher score

VivioMDFactor scores not reassessed.
Site position #433

Lower score

Score comparison

RxSpan MD has the higher recorded score — 84.3/100 to 57.4/100.

RxSpan MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Before you choose

Neither seller publishes a medication price, so the RxSpan MD review and the VivioMD review are where to see what each one does disclose about fees, renewal and cancellation. Ask both for a written total, including any membership, before deciding.

If neither one fits, RxSpan MD vs Vytora Health and Sesame Care vs VivioMD compare each of them with another graded program, and the list of alternatives to RxSpan MD ranks the programs closest to RxSpan MD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueRxSpan MD +41
86
45
Dose & formulationRxSpan MD +13
89
76
Clinical oversightRxSpan MD +33
88
55
Labs & monitoringRxSpan MD +30
83
53
FulfillmentRxSpan MD +8
89
81
Contract termsRxSpan MD +24
53
29
RxSpan MD · top barVivioMD · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricRxSpan MDVivioMD
WeighScore84.3/10057.4/100
GradeBC
Site position#4#433
SemaglutideCurrent compounded quote unconfirmedNot disclosed
TirzepatideCurrent compounded quote unconfirmedNot disclosed
CoverageConfirm treatment availability during intakeTerms exclude Louisiana; homepage advertises providers in all 50 states
Brand-name accessYesYes
Oral / sublingualNot confirmedNot confirmed
RxSpan MD

Site position #4 · B

Strengths

  • Current public catalog lists Ozempic, Wegovy, Mounjaro and Zepbound
  • Public terms describe independent healthcare providers
  • Homepage describes messaging and care-team appointments

What to consider

  • Homepage advertises compounded plans that the current catalog did not substantiate
  • Current oral GLP-1 availability is unconfirmed
  • Prior compounded prices are not a current quote; selected dose, supply, pharmacy and fee inclusions need confirmation
  • Public terms do not establish unused prepaid-treatment refund amounts
VivioMD

Site position #433 · C

Factor scores not reassessed.

FDAWarning letter issued to VivioMD Group LLC dba VivioMD in June 2026. See the FDA warning-letter database.

Strengths

  • Terms identify OpenLoop clinical groups and list RedRock, Health Warehouse and Triad Rx
  • Public refund policy states the renewal cancellation cutoff

What to consider

  • Reviewed homepage does not show drug-specific pricing
  • Terms exclude Louisiana despite nationwide provider language
  • Cancellation requests must arrive at least 72 hours before the next bill
  • Compounded medications are not FDA-approved

Featured provider

RxSpan MD

RxSpan MD scores 84.3/100 (B). RxSpan MD's live catalog lists brand-name GLP-1 drugs, while its homepage also advertises compounded plans; confirm the actual product and total price before enrolling.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard